Prevalence and risk factors associated to pruritus in Plasmodium vivax patients using chloroquine in the Brazilian Amazon

Acta Tropica

Volumn 128, Issue 3, 2013, Pages 504-508

  Ballut, Priscilla C ^a   Siqueira, Andre M ^b,c   Orlando, Aline CB ^a   Alexandre, Marcia AA ^a,b,c   Alecrim, Maria Graças C ^a,b,c   Lacerda, Marcus VG ^a,b,c  

^a UNIVERSIDADE NILTON LINS   (Brazil)

^b FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^c UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

Author keywords

Adverse events; Amazon; Chloroquine; Malaria; Plasmodium vivax

Indexed keywords

ANTIHISTAMINIC AGENT; CHLOROQUINE; PRIMAQUINE;

ALLERGY; DISEASE TREATMENT; DRUG; HOST-PARASITE INTERACTION; MALARIA; MULTIVARIATE ANALYSIS; RISK FACTOR;

ADOLESCENT; ADULT; ALLERGY; ARTICLE; BRAZIL; CHILD; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG UTILIZATION; FEMALE; HOST PARASITE INTERACTION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROSCOPY; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARASITEMIA; PATIENT COMPLIANCE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PRURITUS; RISK ASSESSMENT; RISK FACTOR; UNIVARIATE ANALYSIS;

AMAZONIA; LATIN AMERICA;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

ADVERSE EVENTS; AMAZON; CHLOROQUINE; MALARIA; PLASMODIUM VIVAX;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; BRAZIL; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; CROSS-SECTIONAL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PREVALENCE; PRURITUS; RISK FACTORS; YOUNG ADULT;

EID: 84892558869     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2013.07.008     Document Type: Article

References (37)

1. Abila B., Ezeamuzie I.C., Igbigbi P.S., Ambakederemo A.W., Asomugha L. Effects of two antihistamines on chloroquine and histamine induced weal and flare in healthy African volunteers. African Journal of Medicine and Medical Sciences 1994, 23:139-142.
2. Adebayo R.A., Sofowora G.G., Onayemi O., Udoh S.J., Ajayi A.A. Chloroquine-induced pruritus in malaria fever: contribution of malaria parasitaemia and the effects of prednisolone, niacin, and their combination, compared with antihistamine. British Journal of Clinical Pharmacology 1997, 44:157-161.
3. Ademowo O.G., Sodeinde O. Certain red cell genetic factors and prevalence of chloroquine-induced pruritus. African Journal of Medicine and Medical Sciences 2002, 31:341-343.
4. Aghahowa S.E., Obianwu H.O., Isah A.O., Arhewoh I.M. Chloroquine-induced pruritus. Indian Journal of Pharmaceutical Sciences 2010, 72:283-289.
5. Ajayi A.A., Kolawole B.A., Udoh S.J. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching. International Journal of Dermatology 2004, 43:972-977.
6. Alonso P.L., Brown G., Arevalo-Herrera M., Binka F., Chitnis C., Collins F., Doumbo O.K., Greenwood B., Hall B.F., Levine M.M., Mendis K., Newman R.D., Plowe C.V., Rodriguez M.H., Sinden R., Slutsker L., Tanner M. A research agenda to underpin malaria eradication. PLoS Medicine 2011, 8:e1000406.
7. Baird J.K. Resistance to therapies for infection by Plasmodium vivax. Clinical Microbiology Reviews 2009, 22:508-534.
8. Brasil.Ministério da Saúde Guia prático de tratamento da malária no Brasil. 2010, Ministerio da Saúde, Brasília, Brasil.
9. Bussaratid V., Walsh D.S., Wilairatana P., Krudsood S., Silachamroon U., Looareesuwan S. Frequency of pruritus in Plasmodium vivax malaria patients treated with chloroquine in Thailand. Tropical Doctor 2000, 30:211-214.
10. Carlton J.M., Sina B.J., Adams J.H. Why is Plasmodium vivax a neglected tropical diseaseα. PLoS Neglected Tropical Diseases 2011, 5.
11. de Andrade J.G., de Andrade A.L., Araujo E.S., Oliveira R.M., Silva S.A., Martelli C.M., Zicker F. A randomized clinical trial with high dose of chloroquine for treatment of Plasmodium falciparum malaria in Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo 1992, 34:467-473.
12. de Santana Filho F.S., Arcanjo A.R., Chehuan Y.M., Costa M.R., Martinez-Espinosa F.E., Vieira J.L., Barbosa M.G., Alecrim W.D., Alecrim M.G. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerging Infectious Diseases 2007, 13:1125-1126.
13. Douglas N.M., Anstey N.M., Angus B.J., Nosten F., Price R.N. Artemisinin combination therapy for vivax malaria. Lancet Infectious Diseases 2010, 10:405-416.
14. Gama H., Ismael A., Sitoi F., Matola A., Barros H., Lunet N. Factors associated with chloroquine induced pruritus during malaria treatment in Mozambican University students. Gaceta Sanitaria 2009, 23:306-310.
15. George A.O. Chloroquine induced pruritus - questionnaire based epidemiological study. African Journal of Health Science 2004, 11:87-92.
16. Liu Q., Tang Z., Surdenikova L., Kim S., Patel K.N., Kim A., Ru F., Guan Y., Weng H.J., Geng Y., Undem B.J., Kollarik M., Chen Z.F., Anderson D.J., Dong X. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 2009, 139:1353-1365.
17. Magalhaes B.M., Alexandre M.A., Siqueira A.M., Melo G.C., Gimaque J.B., Bastos M.S., Figueiredo R.M., Carvalho R.C., Tavares M.A., Naveca F.G., Alonso P., Bassat Q., Lacerda M.V., Mourao M.P. Clinical profile of concurrent dengue fever and Plasmodium vivax malaria in the Brazilian Amazon: case series of 11 hospitalized patients. American Journal of Tropical Medicine and Hygiene 2012, 87:1119-1124.
18. Michel P., Quenon J.L., de Sarasqueta A.M., Scemama O. Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals. BMJ 2004, 328:199.
19. Mnyika K.S., Kihamia C.M. Chloroquine-induced pruritus: its impact on chloroquine utilization in malaria control in Dar es Salaam. Journal of Tropical Medicine and Hygiene 1991, 94:27-31.
20. Mueller I., Galinski M.R., Baird J.K., Carlton J.M., Kochar D.K., Alonso P.L., del Portillo H.A. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infectious Diseases 2009, 9:555-566.
21. Ogunranti J.O., Aguiyi J.C., Roma S., Onwukeme K.E. Chloroquine-induced pruritus and sickle cell gene trait in Africans: possible pharmacogenetic relationship. European Journal of Clinical Pharmacology 1992, 43:323-324.
22. Okor R.S. Responsiveness of chloroquine-induced pruritus to antihistamine therapy - a clinical survey. Journal of Clinical Pharmacy and Therapeutics 1990, 15:147-150.
23. Olatunde I.A. Chloroquine concentrations in the skin of rabbits and man. British Journal of Pharmacology 1971, 43:335-340.
24. Olayemi O., Fehintola F.A., Osungbade A., Aimakhu C.O., Udoh E.S., Adeniji A.R. Pattern of chloroquine-induced pruritus in antenatal patients at the University College Hospital, Ibadan. Journal of Obstetrics and Gynaecology 2003, 23:490-495.
25. Oliveira-Ferreira J., Lacerda M.V., Brasil P., Ladislau J.L., Tauil P.L., Daniel-Ribeiro C.T. Malaria in Brazil: an overview. Malaria Journal 2010, 9:115.
26. Onyeji C.O., Ogunbona F.A. Pharmacokinetic aspects of chloroquine-induced pruritus: influence of dose and evidence for varied extent of metabolism of the drug. European Journal of Pharmaceutical Sciences 2001, 13:195-201.
27. Osifo N.G. Chloroquine-induced pruritus among patients with malaria. Archives of Dermatology 1984, 120:80-82.
28. Pereira E.A., Ishikawa E.A., Fontes C.J. Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region. Malaria Journal 2011, 10:355.
29. Price R.N., Douglas N.M., Anstey N.M., von Seidlein L. Plasmodium vivax treatments: what are we looking forα. Current Opinion in Infectious Diseases 2011, 24:578-585.
30. Pukrittayakamee S., Imwong M., Looareesuwan S., White N.J. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Tropica 2004, 89:351-356.
31. Sistema de Informações Operacionais e Epidemiológicas - Fundação de Medicina Tropical Dr.Heitor Vieira Dourado Sistema de Informações Operacionais e Epidemiológicas - Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. 2012.
32. Sowunmi A., Walker O., Salako L.A. Pruritus and antimalarial drugs in Africans. Lancet 1989, 2:213.
33. Sun Y.G., Zhao Z.Q., Meng X.L., Yin J., Liu X.Y., Chen Z.F. Cellular basis of itch sensation. Science 2009, 325:1531-1534.
34. Taylor W.R., White N.J. Antimalarial drug toxicity: a review. Drug Safety 2004, 27:25-61.
35. Tey H.L., Yosipovitch G. Itch in ethnic populations. Acta Dermato-Venereologica 2010, 90:227-234.
36. WHO Guidelines for the Treatment of Malaria 2010, World Health Organization, Geneva. 2nd ed.
37. WHO World Malaria Report 2011, World Health Organization, Geneva.